Citigroup Keeps Neutral Ratings on Eight Companies
Citigroup maintained Neutral ratings on eight companies. Targets for Merck and Zebra rose, while those for INNIO, Oshkosh and EquipmentShare.com fell.
central bank decisions, rates, inflation and data releases, explained through their market impact.
stories appear here with a 15-minute delay. in real time — via the api connect the api →
Citigroup maintained Neutral ratings on eight companies. Targets for Merck and Zebra rose, while those for INNIO, Oshkosh and EquipmentShare.com fell.
Citigroup lifted its price targets for Ametek, Ralliant and Aramark. The bank also maintained a Buy rating on Aramark.
Nexxen appointed Senior Independent Director Neil Jones interim board chair after Christopher Stibbs left, while Daniel Kerstein took over a key committee.
Humana will publish third-quarter 2026 results and management remarks on November 6, followed by an investor Q&A webcast on results and 2026 guidance.
FIS said it will release third-quarter 2026 results before market open on November 3 and webcast its earnings call for the investment community.
Biomea Fusion will release Phase I GLP-131 results for BMF-650 on October 13 and hold an investor conference call and webcast to discuss the data.
Citigroup maintained Buy ratings on APi Group and Parker-Hannifin while raising their share-price targets to $55.00 and $1234.00.
Citigroup raised its price target for Eaton Corp. to $498.00 per share from $485.00, according to Benzinga’s report on analyst rating actions.
Trump’s new committee will reopen the case against Fed Governor Lisa Cook, setting up another test of the central bank’s political independence.
Citigroup lowered its price target for Honeywell Technologies to $270.00 per share from $279.00, according to Benzinga ratings actions.
Wells Fargo lowered Zillow’s price target from $35 to $31 while keeping an Equal Weight rating. The shares closed down 4% at $28.69.
HPE shares fell 4.4% after Evercore ISI cut its rating, saying the valuation looked stretched following a strong rally in the stock.
Artisan Partners shares fell 3.3% after TD Cowen cut its target to $33. Preliminary assets under management missed the analyst’s estimate.
FormFactor and Teradyne will work to accelerate semiconductor test solutions. Teradyne is also making a strategic $300 million equity investment.
Newsmetry API reports that Syndax’s axatilimab missed the main Phase 2 goal in idiopathic pulmonary fibrosis, ending plans for further development.
RTX reported naval radar software work, three Coyote interceptor tests and broader Collins Aerospace maintenance coverage for 44 Vietjet aircraft.
FormFactor and Teradyne will cooperate on semiconductor-testing systems, while Teradyne plans a $300 million strategic equity investment in FormFactor.
Navitas and NVIDIA developed a 24 kW board that converts 800 VDC directly to 12 VDC for AI data centers, removing the 50 V IBC stage.
Global Ship Lease agreed a seven-year $1 billion loan facility at SOFR plus 1.5% to fund the delivery of 15 new containerships from 2028 to 2030.
Nurix Therapeutics reported $673.06 million in third-quarter revenue, lifted by Roche license income and a Sanofi milestone payment.